In EG7 tumor-bearing mice, in vitro butyrate-pretreated OT-I CD8+ T cells demonstrated enhanced antitumor activity, characterized by improved tumor infiltration and increased IFN-γ secretion. The gene discussed is CD8A; the disease is neoplasm.